药理干预措施在应力头痛预防治疗中的比较效果:系统性审查和网络元分析
Qing-Feng Tao1, Can Hua2, Jian-Jiao Mou1
1Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Annals of medicine
|January 18, 2026
概括
阿米特利普提林100mg和BTX-A 100U可能会减少慢性紧张型头痛 (TTH) 的每月头痛日数. 然而,证据质量较低,需要进一步研究来证实有效性和安全性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 紧张型头痛 (TTH) 是全球最常见的神经疾病.
- 对TTH的预防性药理疗法的比较疗效尚未得到充分证实.
- 这项研究评估了TTH预防的各种药理干预措施.
研究的目的:
- 为了比较不同的药理干预措施在预防张力类型头痛方面的有效性.
- 评估每月头痛天数的减少作为主要结果.
- 根据其在慢性TTH预防中的有效性来对治疗进行排名.
主要方法:
- 进行了随机对照试验 (RCT) 的系统审查和元分析.
- 在Ovid Medline,Embase和Cochrane数据库中进行了搜索,截至2025年12月12日.
- 贝叶斯随机效应模型被用来分析35个RCT的数据,重点是慢性TTH患者.
主要成果:
- 与安慰剂相比,在4周和8周内,阿米特利普提林100mg显著减少了每月头痛的日子.
- 毒素A (BTX-A) 100U也显示了每月头痛日数的减少.
- 在多个时间点的有效性方面,阿米林100mg的排名最高,而BTX-A 500U显示不良事件增加.
结论:
- 阿米特利普提林100mg和BTX-A 100U显示出降低慢性TTH中头痛频率的潜力.
- 目前的证据确定性低至非常低,存在偏见和异质性高风险.
- 进一步进行高质量的研究对于验证这些发现和指导临床实践至关重要.
相关概念视频
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.5K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.5K
01:25Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K